David Sinclair plans human tests of age reversal drug

David Sinclair plans human tests of a reprogramming drug in a $101 million XPrize competition. The grand prize goes to a team showing a 10 year relative improvement after one year of treatment. Sinclair will give an oral drug mixture to volunteers seeking evidence for age restoration in humans.